A lot of the people we see from Tucker did not gain weight quickly. They gained it over fifteen or twenty years in the same wooded neighborhood, raising kids in Smoke Rise or Idlewood, working through a career, absorbing a knee injury here and a stressful stretch there. Walking loops at Henderson Park on Saturday is a good thing to do, and it is rarely enough on its own once metabolism, medications, and hormones are part of the picture. A medical evaluation is what separates a plan that fits your body from another round of general advice.
Atlanta Medical Institute keeps one office, in Buckhead at 5009 Roswell Road NE, and patients travel to us rather than the other way around. From Tucker, most people pick up I-285 at LaVista Road or Chamblee Tucker Road, follow the Perimeter west to the Roswell Road exit, then head south past Chastain Park to the office. We see patients Monday through Thursday from 9 to 6 and Friday from 9 to 4, which gives commuters room to schedule before the westbound Perimeter fills up or after it clears.
What a plan includes depends entirely on what the evaluation shows. For some patients that means nutrition and activity changes built around a real schedule. For others it means prescription medication, including GLP-1 therapy, when a physician determines it is appropriate. Results vary from person to person, and no one here will tell you a number before knowing your history. What we can commit to is a physician looking at the whole picture, explaining the options plainly, and staying with you through follow-up visits rather than handing you a plan and disappearing.
About Medical Weight Loss
Medical weight loss is what it sounds like: weight management handled as medical care rather than as a diet plan. Obesity is now understood as a chronic, relapsing metabolic condition, not a matter of willpower, and it is treated the way other chronic conditions are treated. That means a physician takes a history, orders labs, looks for the things that quietly make weight loss harder such as thyroid dysfunction, insulin resistance, sleep apnea, or a medication you are already taking that promotes weight gain, and then builds a plan around what the evaluation actually shows.
Atlanta Medical Institute has provided physician-supervised weight management from its office on Roswell Road since 2010. Care is directed by Dr. Elbridge Bills, Dr. Jeff Semel, and Dr. Leslye Pace, and a typical program combines a nutrition and activity strategy you can sustain, treatment of the underlying metabolic issues found on evaluation, prescription medication when it is clinically appropriate, and scheduled follow-up so the plan can be adjusted as your body responds. Patients travel to the Atlanta office from across the metro area and from well outside it.
Prescription options, including the GLP-1 and dual-agonist medications that have changed obesity treatment over the last several years, are genuinely effective tools for many people. They are also prescription drugs with real contraindications, real side effects, and a real need for monitoring. Nobody at AMI can tell you in advance whether a particular medication is right for you. Eligibility is determined by a medical evaluation, and your physician decides what to prescribe, at what dose, and for how long.
What a Medical Weight Loss Program Involves
The first visit is an evaluation, not a sales pitch. Your physician reviews your weight history, what you have already tried, your current medications and supplements, your family history, and any conditions that affect how your body handles food and energy. Height, weight, blood pressure, and body measurements are taken, and lab work is usually ordered to establish a baseline.
From there the plan is individual. Some patients need nutrition structure and accountability more than anything else. Others have an underlying metabolic or hormonal problem that has to be addressed before the scale moves at all. Many do best with a combination of lifestyle work and medication. Follow-up visits are part of the treatment rather than an add-on, because dosing, labs, and the nutrition plan all get adjusted based on how you are actually responding.
- A medical history and physical focused on weight-related conditions
- Baseline lab work, which commonly includes metabolic panel, lipids, A1c or fasting glucose, and thyroid function
- Review of current prescriptions for medications that contribute to weight gain
- A nutrition and activity plan built around your schedule, budget, and medical limitations
- Prescription therapy when your physician determines it is appropriate and safe for you
- Regular follow-up visits to track progress, adjust dosing, and recheck labs
Prescription Options Your Physician May Discuss
The GLP-1 receptor agonists and the dual GIP/GLP-1 agonists are the most effective medications currently available for chronic weight management. Semaglutide is FDA-approved for chronic weight management under the brand name Wegovy and for type 2 diabetes as Ozempic. Tirzepatide is approved for chronic weight management as Zepbound and for type 2 diabetes as Mounjaro. They work mainly by slowing gastric emptying and acting on appetite signaling in the brain, which is why most patients describe reduced hunger and earlier fullness rather than a stimulant effect.
Compounded versions of these drugs became widely available during the national shortages of 2022 through 2024. Those shortages have since resolved, and in 2026 the FDA moved to further restrict large-scale compounding of semaglutide and tirzepatide, citing adverse event reports that included dosing errors with multi-dose vials. This is worth understanding before you start: compounded product is not FDA-approved, is not reviewed for potency or purity the way approved product is, and your physician should tell you plainly which you are being prescribed and why.
GLP-1s are not the only option, and they are not right for everyone. Older FDA-approved medications including phentermine, phentermine/topiramate, and naltrexone/bupropion typically produce more modest weight reduction but remain reasonable choices for some patients based on cost, tolerance, medical history, or response. Some patients do well without any medication at all.
Who Is a Candidate
FDA labeling and major clinical guidelines generally set the threshold for weight-management pharmacotherapy at a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, dyslipidemia, type 2 diabetes, or obstructive sleep apnea. BMI is a starting point rather than the whole picture, and your physician will weigh it alongside body composition, labs, and your medical history.
Some histories rule these medications out or call for real caution. GLP-1 and dual-agonist medications are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and in anyone with a known serious hypersensitivity to the drug. A history of pancreatitis, gastroparesis or significant gastrointestinal disease, advanced kidney disease, diabetic retinopathy, active eating disorder, pregnancy or planning pregnancy, and breastfeeding all require a careful conversation before anything is prescribed.
This is the practical reason a medical evaluation comes first. A questionnaire cannot catch a family history of thyroid cancer or an interaction with a drug you are already on. Bring your full medication list, including supplements, to your first visit.
- BMI of 30 or more, or 27 or more with a weight-related medical condition
- No personal or family history of medullary thyroid carcinoma or MEN 2 for incretin therapy
- Willingness to attend follow-up visits and have labs monitored
- Full disclosure of current medications, prior pancreatitis, and gastrointestinal history
- Not pregnant, planning pregnancy, or breastfeeding
Safety, Monitoring, and What to Expect
GLP-1 and dual-agonist medications are started at a low dose and increased gradually. That schedule exists for a reason: the most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and reflux, and escalating too quickly makes them worse. Most of these effects ease as the body adjusts, and slowing the titration is often the right answer when they do not. More serious but less common concerns include pancreatitis, gallbladder disease, and, in patients with type 2 diabetes on insulin or sulfonylureas, low blood sugar. Report severe or persistent abdominal pain to your physician promptly.
Because these medications delay gastric emptying, tell any surgeon, anesthesiologist, or proceduralist that you are taking one before a planned procedure. Follow their fasting instructions exactly.
Muscle matters during rapid weight loss. Studies of incretin-based therapy have found that a meaningful share of the total weight lost can come from lean mass, so adequate protein intake and resistance training are treated as part of the protocol rather than as optional extras. Hydration, fiber, and attention to micronutrients help as well.
Be realistic about the long term. Trial data on both semaglutide and tirzepatide show that most patients regain a substantial portion of lost weight within a year of stopping, along with partial reversal of the metabolic improvements. That does not mean treatment failed. It means obesity behaves like other chronic conditions, and the plan for maintenance, whether that is continued medication, a reduced maintenance dose, or a structured lifestyle program, is something to discuss with your physician while you are still losing rather than after.
Getting Here from Tucker
Most patients from Tucker pick up I-285 at LaVista Road or Chamblee Tucker Road and follow the Perimeter west to the Roswell Road exit, then head south on Roswell Road NE past Chastain Park to the office at 5009 Roswell Road NE.
5009 Roswell Road NE, Suite 201
Atlanta, GA 30342
We see patients from across Tucker and nearby areas including Smoke Rise, Idlewood, Northlake, Brockett, Midvale.
Medical Weight Loss in Tucker — Frequently Asked Questions
Does Atlanta Medical Institute have an office in Tucker?
No. We have one office, at 5009 Roswell Road NE, Suite 201, in Atlanta's Buckhead area. We serve patients who travel in from Tucker and the rest of northeast DeKalb County. Most drive west on I-285 from LaVista Road or Chamblee Tucker Road to the Roswell Road exit.
How often would I need to come in from Tucker?
Visit frequency depends on your plan and how you respond to it. Early in treatment, follow-up tends to be more frequent so your physician can review progress, side effects, and lab work, then adjust. Your physician will set a schedule with you at your first visit.
Do I need to be at a certain weight to start?
There is no single cutoff. Eligibility for any given treatment is determined by medical evaluation, including your weight history, labs, current medications, and any related conditions such as high blood pressure or prediabetes. Some patients are candidates for medication; others are better served by a different approach.
How much weight will I lose?
No honest clinic will give you a number in advance. Results vary widely based on your starting point, your metabolic health, which treatment you and your physician choose, and how consistently you can follow the plan. Published trials of the newer incretin medications show substantial average reductions, but averages are not promises, and some patients respond much less than others. Your physician will set realistic expectations with you after your evaluation.
Do I have to take medication to be in the program?
No. Medication is one tool among several. Some patients come in with an untreated thyroid or hormonal issue that is doing most of the damage, and addressing that changes everything. Others need nutrition structure and regular accountability. Your physician will recommend medication only if the evaluation supports it and nothing in your history argues against it.
What is the difference between Wegovy, Ozempic, Zepbound, and Mounjaro?
Wegovy and Ozempic are both semaglutide; Wegovy is FDA-approved for chronic weight management and Ozempic for type 2 diabetes. Zepbound and Mounjaro are both tirzepatide, approved for chronic weight management and type 2 diabetes respectively. The diabetes and weight-management versions differ in their approved indications and dosing, which is part of why the prescribing decision belongs with a physician who knows your history.
Is compounded semaglutide or tirzepatide the same as the brand-name drug?
No. Compounded preparations are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, potency, or purity. They became common during the 2022 to 2024 shortages, which have since resolved, and in 2026 the FDA moved to further restrict large-scale compounding of these ingredients after adverse event reports that included serious dosing errors. Ask any provider directly whether they are prescribing FDA-approved product or a compounded preparation, and why.
Will my insurance cover this?
Coverage for weight-management medication varies a great deal by plan, and many plans that cover these drugs for type 2 diabetes do not cover them for weight management, or require documentation first. Because plan terms change, the most reliable answer comes from calling our office at (404) 341-4819 so we can talk through your specific situation rather than quoting you something that may not apply.
What happens if I stop the medication?
Most patients regain a significant portion of the weight within about a year of stopping, and the improvements in blood pressure, lipids, and blood sugar tend to partially reverse alongside it. This is well documented in the extension data for both semaglutide and tirzepatide. It reflects the biology of obesity as a chronic condition rather than a personal failure. Talk with your physician about a maintenance plan before you stop, not after.
Want the full clinical detail? Read about our Weight Loss Atlanta GA program.